Literature DB >> 11830198

Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study.

Sabine Bahn1, Michael Mimmack, Margaret Ryan, Maeve A Caldwell, Eric Jauniaux, Michael Starkey, Clive N Svendsen, Piers Emson.   

Abstract

BACKGROUND: Identification of genes and characterisation of their function is an essential step towards understanding complex pathophysiological abnormalities in Down's syndrome. We did a study to investigate abnormalities in gene expression in human neuronal stem cells and progenitor cells from Down's syndrome and control post-mortem human fetal tissue.
METHODS: Indexing-based differential display PCR was done on neuronal precursor cells derived from the cortex of a fetus with Down's syndrome, and findings were compared with those of two control samples. Findings were validated against neurosphere preparations from three independent Down's syndrome fetuses and five independent controls by real-time quantitative PCR.
FINDINGS: Results of differential display PCR analysis showed that SCG10--a neuron--specific growth-associated protein regulated by the neuron-restrictive silencer factor REST-was almost undetectable in the Down's syndrome sample. This finding was validated by real-time PCR. We also found that other genes regulated by the REST transcription factor were selectively repressed, whereas non-REST-regulated genes with similar functions were unaffected. Changes in expression of several key developmental genes in the Down's syndrome stem-cell and progenitor-cell pool correlated with striking changes in neuron morphology after differentiation.
INTERPRETATION: Our findings suggest a link between dysregulation of the REST transcription factor and some of the neurological deficits seen in Down's syndrome. Experimental REST downregulation has been shown to trigger apoptosis, which could account for the striking and selective loss of neurons in the differentiated Down's syndrome cell preparations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830198     DOI: 10.1016/S0140-6736(02)07497-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  68 in total

Review 1.  Functional genomics and proteomics: application in neurosciences.

Authors:  K E Wilson; M M Ryan; J E Prime; D P Pashby; P R Orange; G O'Beirne; J G Whateley; S Bahn; C M Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

2.  The enemy within: intronic miR-26b represses its host gene, ctdsp2, to regulate neurogenesis.

Authors:  Jinju Han; Ahmet M Denli; Fred H Gage
Journal:  Genes Dev       Date:  2012-01-01       Impact factor: 11.361

Review 3.  Human stem cells and drug screening: opportunities and challenges.

Authors:  Allison D Ebert; Clive N Svendsen
Journal:  Nat Rev Drug Discov       Date:  2010-03-26       Impact factor: 84.694

4.  Gene expression analysis of the function of the male-specific lethal complex in Drosophila.

Authors:  Manika Pal Bhadra; Utpal Bhadra; Joydeep Kundu; James A Birchler
Journal:  Genetics       Date:  2005-02-16       Impact factor: 4.562

5.  Generation of neural stem cells from discarded human fetal cortical tissue.

Authors:  Jie Lu; Laurent C Delli-Bovi; Jonathan Hecht; Rebecca Folkerth; Volney L Sheen
Journal:  J Vis Exp       Date:  2011-05-25       Impact factor: 1.355

6.  Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation.

Authors:  Sonja M Sachse; Sam Lievens; Luís F Ribeiro; Dan Dascenco; Delphine Masschaele; Katrien Horré; Anke Misbaer; Nele Vanderroost; Anne Sophie De Smet; Evgenia Salta; Maria-Luise Erfurth; Yoshiaki Kise; Siegfried Nebel; Wouter Van Delm; Stéphane Plaisance; Jan Tavernier; Bart De Strooper; Joris De Wit; Dietmar Schmucker
Journal:  EMBO J       Date:  2019-02-11       Impact factor: 11.598

7.  DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.

Authors:  Xiao-Yan Tang; Lei Xu; Jingshen Wang; Yuan Hong; Yuanyuan Wang; Qian Zhu; Da Wang; Xin-Yue Zhang; Chun-Yue Liu; Kai-Heng Fang; Xiao Han; Shihua Wang; Xin Wang; Min Xu; Anita Bhattacharyya; Xing Guo; Mingyan Lin; Yan Liu
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

8.  REST and the RESTless: in stem cells and beyond.

Authors:  Vidya Gopalakrishnan
Journal:  Future Neurol       Date:  2009

9.  Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia.

Authors:  Russell J Ferland; Luis Federico Batiz; Jason Neal; Gewei Lian; Elizabeth Bundock; Jie Lu; Yi-Chun Hsiao; Rachel Diamond; Davide Mei; Alison H Banham; Philip J Brown; Charles R Vanderburg; Jeffrey Joseph; Jonathan L Hecht; Rebecca Folkerth; Renzo Guerrini; Christopher A Walsh; Esteban M Rodriguez; Volney L Sheen
Journal:  Hum Mol Genet       Date:  2008-11-07       Impact factor: 6.150

10.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.